Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer.

Liu Y, Zhou Y, Feng X, Yang P, Yang J, An P, Wang H, Ye S, Yu C, He Y, Luo H.

Genes Chromosomes Cancer. 2014 Apr;53(4):358-65. doi: 10.1002/gcc.22146. Epub 2014 Jan 29.

PMID:
24532280
2.
3.

Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.

Fukushima Y, Iinuma H, Tsukamoto M, Matsuda K, Hashiguchi Y.

Oncol Rep. 2015 Feb;33(2):573-82. doi: 10.3892/or.2014.3614. Epub 2014 Nov 21.

PMID:
25421755
4.

Prognostic significance of microRNA-16 expression in human colorectal cancer.

Qian J, Jiang B, Li M, Chen J, Fang M.

World J Surg. 2013 Dec;37(12):2944-9. doi: 10.1007/s00268-013-2205-4.

PMID:
24045965
5.

Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.

Li H, Dai S, Zhen T, Shi H, Zhang F, Yang Y, Kang L, Liang Y, Han A.

Eur J Cancer. 2014 Apr;50(6):1207-21. doi: 10.1016/j.ejca.2013.12.010. Epub 2014 Jan 9.

PMID:
24412052
6.

Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.

Wang X, Wang J, Ma H, Zhang J, Zhou X.

Med Oncol. 2012 Jun;29(2):919-27. doi: 10.1007/s12032-011-9880-5. Epub 2011 Mar 10.

PMID:
21390519
7.

Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.

Zhou T, Zhang GJ, Zhou H, Xiao HX, Li Y.

Eur J Gastroenterol Hepatol. 2014 Feb;26(2):229-33. doi: 10.1097/MEG.0000000000000002.

PMID:
24150523
8.

Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.

Zhou T, Zhang G, Liu Z, Xia S, Tian H.

Int J Colorectal Dis. 2013 Jan;28(1):19-24. doi: 10.1007/s00384-012-1528-1. Epub 2012 Jul 7.

PMID:
22772712
9.

Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer.

Chen P, Xi Q, Wang Q, Wei P.

Med Oncol. 2014 Oct;31(10):235. doi: 10.1007/s12032-014-0235-x. Epub 2014 Sep 13.

PMID:
25216869
10.

Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.

Horiuchi A, Iinuma H, Akahane T, Shimada R, Watanabe T.

Oncol Rep. 2012 May;27(5):1384-92. doi: 10.3892/or.2012.1648. Epub 2012 Jan 19.

PMID:
22267128
11.

Relationship between miRNA-338-3p expression and progression and prognosis of human colorectal carcinoma.

Sun K, Su G, Deng H, Dong J, Lei S, Li G.

Chin Med J (Engl). 2014;127(10):1884-90.

PMID:
24824250
12.

MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1.

Ji D, Chen Z, Li M, Zhan T, Yao Y, Zhang Z, Xi J, Yan L, Gu J.

Mol Cancer. 2014 Apr 23;13:86. doi: 10.1186/1476-4598-13-86.

13.

The expression of miR-25 is increased in colorectal cancer and is associated with patient prognosis.

Li X, Yang C, Wang X, Zhang J, Zhang R, Liu R.

Med Oncol. 2014 Jan;31(1):781. doi: 10.1007/s12032-013-0781-7. Epub 2013 Nov 29.

PMID:
24293092
14.

MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways.

Liu Y, Zhou Y, Feng X, An P, Quan X, Wang H, Ye S, Yu C, He Y, Luo H.

Int J Oncol. 2014 Jan;44(1):203-10. doi: 10.3892/ijo.2013.2168. Epub 2013 Nov 5.

PMID:
24189753
15.

MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity via EGFR regulation.

Suto T, Yokobori T, Yajima R, Morita H, Fujii T, Yamaguchi S, Altan B, Tsutsumi S, Asao T, Kuwano H.

Carcinogenesis. 2015 Mar;36(3):338-45. doi: 10.1093/carcin/bgu242. Epub 2014 Dec 10.

PMID:
25503932
16.

Overexpression of miR-223 correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.

Li ZW, Yang YM, Du LT, Dong Z, Wang LL, Zhang X, Zhou XJ, Zheng GX, Qu AL, Wang CX.

Med Oncol. 2014 Nov;31(11):256. doi: 10.1007/s12032-014-0256-5. Epub 2014 Oct 1.

PMID:
25270282
17.

Clinical significance of miR-22 expression in patients with colorectal cancer.

Zhang G, Xia S, Tian H, Liu Z, Zhou T.

Med Oncol. 2012 Dec;29(5):3108-12. doi: 10.1007/s12032-012-0233-9. Epub 2012 Apr 11.

PMID:
22492279
18.

MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.

Sümbül AT, Göğebakan B, Bayram S, Batmacı CY, Öztuzcu S.

Tumour Biol. 2015 Dec;36(12):9703-9. doi: 10.1007/s13277-015-3708-4. Epub 2015 Jul 8.

PMID:
26152286
19.

Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.

Xie Y, Song J, Zong Q, Wang A, Yang Y, Liu F, Meng X.

Hepatogastroenterology. 2015 May;62(139):615-9.

PMID:
26897940
20.

MicroRNA-149 suppresses colorectal cancer cell migration and invasion by directly targeting forkhead box transcription factor FOXM1.

Xu K, Liu X, Mao X, Xue L, Wang R, Chen L, Chu X.

Cell Physiol Biochem. 2015;35(2):499-515. doi: 10.1159/000369715. Epub 2015 Jan 16.

Supplemental Content

Support Center